Compare Jenscare Scientific Co. Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Net Sales has grown by an annual rate of 2.29% and Operating profit at -440.15% over the last 5 years
- The company is Net-Debt Free
2
Flat results in Dec 25
3
Risky -
4
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
HKD 2,231 Million ()
NA (Loss Making)
NA
0.00%
-0.61
-999,999.00%
2.54
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2021)
Net Profit:
-375 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.36%
0%
-20.36%
6 Months
-15.74%
0%
-15.74%
1 Year
-11.18%
0%
-11.18%
2 Years
103.5%
0%
103.5%
3 Years
-75.33%
0%
-75.33%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Jenscare Scientific Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.29%
EBIT Growth (5y)
-440.15%
EBIT to Interest (avg)
-114.15
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.58
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.56
EV to EBIT
-3.75
EV to EBITDA
-3.78
EV to Capital Employed
5.00
EV to Sales
1713.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-133.09%
ROE (Latest)
-51.37%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
98.20
0.00
Operating Profit (PBDIT) excl Other Income
-241.60
-221.90
-8.88%
Interest
0.90
0.30
200.00%
Exceptional Items
1.60
4.50
-64.44%
Consolidate Net Profit
-295.80
-201.50
-46.80%
Operating Profit Margin (Excl OI)
-2,615.00%
0.00%
-261.50%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -46.80% vs 51.90% in Dec 2024
About Jenscare Scientific Co. Ltd. 
Jenscare Scientific Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






